These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 25874605)

  • 1. The Interplay between Alpha-Synuclein Clearance and Spreading.
    Lopes da Fonseca T; Villar-Piqué A; Outeiro TF
    Biomolecules; 2015 Apr; 5(2):435-71. PubMed ID: 25874605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy.
    Tanik SA; Schultheiss CE; Volpicelli-Daley LA; Brunden KR; Lee VM
    J Biol Chem; 2013 May; 288(21):15194-210. PubMed ID: 23532841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond α-synuclein transfer: pathology propagation in Parkinson's disease.
    Hansen C; Li JY
    Trends Mol Med; 2012 May; 18(5):248-55. PubMed ID: 22503115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein.
    Kang SJ; Kim SJ; Noh HR; Kim BJ; Kim JB; Jin U; Park SA; Park SM
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cleaning Crew: The Pursuit of Autophagy in Parkinson's Disease.
    Parekh P; Sharma N; Gadepalli A; Shahane A; Sharma M; Khairnar A
    ACS Chem Neurosci; 2019 Sep; 10(9):3914-3926. PubMed ID: 31385687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder?
    Olanow CW; Brundin P
    Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
    Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
    Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dual role of c-src in cell-to-cell transmission of α-synuclein.
    Choi YR; Kim JB; Kang SJ; Noh HR; Jou I; Joe EH; Park SM
    EMBO Rep; 2020 Jul; 21(7):e48950. PubMed ID: 32372484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein Propagation Mouse Models of Parkinson's Disease.
    Uemura N; Ueda J; Okuda S; Sawamura M; Takahashi R
    Methods Mol Biol; 2021; 2322():119-130. PubMed ID: 34043198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prion-like spreading of α-synuclein: From in vitro to in vivo models of Parkinson's disease.
    Vargas JY; Grudina C; Zurzolo C
    Ageing Res Rev; 2019 Mar; 50():89-101. PubMed ID: 30690184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of de novo α-synuclein fibrillization in a neuronal model for Parkinson's disease.
    Fares MB; Maco B; Oueslati A; Rockenstein E; Ninkina N; Buchman VL; Masliah E; Lashuel HA
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E912-21. PubMed ID: 26839406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.
    Rey NL; George S; Brundin P
    Neuropathol Appl Neurobiol; 2016 Feb; 42(1):51-76. PubMed ID: 26666838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new perspective in Parkinson's disease, chaperone-mediated autophagy.
    Li B; Zhang Y; Yuan Y; Chen N
    Parkinsonism Relat Disord; 2011 May; 17(4):231-5. PubMed ID: 21215675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.
    Xu S; Chan P
    Biomolecules; 2015 Jun; 5(2):1122-42. PubMed ID: 26057626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson disease.
    Kim KS; Choi YR; Park JY; Lee JH; Kim DK; Lee SJ; Paik SR; Jou I; Park SM
    J Biol Chem; 2012 Jul; 287(30):24862-72. PubMed ID: 22619171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
    Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between coxsackievirus B3 infection and α-synuclein in models of Parkinson's disease.
    Park SJ; Jin U; Park SM
    PLoS Pathog; 2021 Oct; 17(10):e1010018. PubMed ID: 34695168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The misfolding mystery: α-synuclein and the pathogenesis of Parkinson's disease.
    Negi S; Khurana N; Duggal N
    Neurochem Int; 2024 Jul; 177():105760. PubMed ID: 38723900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.